|
Volumn 46, Issue 6, 2020, Pages 1124-1126
|
Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
FIBRIN;
ACUTE LUNG INJURY;
BLOOD VESSEL INJURY;
CORONAVIRUS DISEASE 2019;
CORTICOSTEROID THERAPY;
CRITICALLY ILL PATIENT;
DISEASE COURSE;
DISEASE SEVERITY;
FEVER;
FIBRIN DEPOSITION;
HEART RIGHT LEFT SHUNT;
HISTOLOGY;
HUMAN;
LETTER;
LEYDIG CELL;
LUNG COMPLIANCE;
LUNG FIBROBLAST;
LUNG INJURY;
LUNG WEIGHT;
ORGANIZING PNEUMONIA;
PHENOTYPE;
POSITIVE END EXPIRATORY PRESSURE;
PULMONARY ARTERY;
VIRUS PNEUMONIA;
BETACORONAVIRUS;
CORONAVIRUS INFECTION;
CRITICAL ILLNESS;
PANDEMIC;
BETACORONAVIRUS;
CORONAVIRUS INFECTIONS;
CRITICAL ILLNESS;
HUMANS;
LUNG INJURY;
PANDEMICS;
PHENOTYPE;
PNEUMONIA, VIRAL;
|
EID: 85083792093
PISSN: 03424642
EISSN: 14321238
Source Type: Journal
DOI: 10.1007/s00134-020-06057-8 Document Type: Letter |
Times cited : (214)
|
References (5)
|